Zinger Key Points
- Charlie Bachtell was a keynote speaker at the 2022 Benzinga Cannabis Capital Conference.
- He said cannabis businesses face the challenges of a lack of regular financial services, and high taxation.
- Markets are swinging wildly, but for Matt Maley, it's just another opportunity to trade. His clear, simple trade alerts have helped members lock in gains as high as 100% and 450%. Now, you can get his next trade signal—completely free.
Cresco Labs Inc CRLBF recently announced plans to acquire Columbia Care Inc CCHWF, marking another round of industrial consolidation in the cannabis sector.
Cresco CEO Charlie Bachtell, a keynote speaker at the 2022 Benzinga Cannabis Capital Conference, said on Tuesday that the acquisition is imperative to its strategic rapid footprint, as Cresco now has a presence in 18 markets.
“We’re executing our thesis and our strategy, which is to build the most strategic geographic footprint that we can,” Bachtell said. “When we bring the Columbia Care footprint and Cresco together — that’ll contribute to at least $100 million at the level of geographic diversification.”
From a shielding standpoint, the acquisition makes sense given the situation of the market at the moment. Risks associated with regulatory change and unforeseen supply chain problems will be less of a concern for Cresco.
Greater depth and leadership positions throughout numerous states will be made possible by the combination of the two businesses. With an estimated $1.4 billion in annual revenue, the combined company said the purchase will give Cresco the highest yearly revenue in the sector.
The merger comes as the marijuana business continues to struggle due to the federal government's resistance to legalizing the drug, a lack of regular financial services, and high taxation. According to Bachtell, federal reform of some kind would increase the flow of money to marijuana businesses.
“If you look at the big four [marijuana companies], all of us could’ve saved between an extra $40 and $80 million in cash if we were taxed as a normal industry,” the CEO said. “That’s a lot of cash flow that could be used.”
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!